JENNIFER SALYERS: Open Payments
NPI 1083483747 · FLATWOODS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 46 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $367 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $161 |
| PFIZER INC. | 12 | $140 |
| Novo Nordisk Inc | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Lilly USA, LLC | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: QULIPTA, NURTEC ODT, VRAYLAR, ELIQUIS, AIRSUPRA, Ozempic, MOUNJARO, JARDIANCE.
Industry payments across KY — which companies pay providers there.
